Document Detail


Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma.
MedLine Citation:
PMID:  19528463     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oral squamous cell carcinoma (SCC) is composed of a heterogeneous population of cells which range anywhere from epithelial to mesenchymal in phenotype. Several oral cancer specimens with antibodies to TRA160, a marker of pluripotent cells, were screened. Compared with the well differentiated lesions, pluripotent cells were more numerous in specimens from poorly differentiated tumors. In vitro, the expression of TRA160 was much greater in invasive oral SCC9beta6 cells compared with the poorly invasive SCC9SN or SCC9beta6D1 cells, which express a truncated beta6. In vitro, pluripotent cells were instrumental in aggressively closing an experimental wound assay. Lastly, TRA-1-60+/beta6+ tumor cells which formed vascular-like structures in vivo were identified. SCC9beta6 cells formed interconnecting channels, whereas SCC9SN cells did not in an in vitro Matrigel angiogenesis assay. The results of this study clearly demonstrated the differential distribution of pluripotent stem cells in oral SCC and that the beta6 integrin may be an important regulatory component of the pluripotent phenotype.
Authors:
Dongmin Dang; Daniel M Ramos
Related Documents :
17098463 - Activity and substrate specificity of pyrimidine phosphorylases and their role in fluor...
2476873 - Immunohistochemical studies of ameloblastoma with special emphasis on keratin.
24239273 - Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  29     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-16     Completed Date:  2009-09-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  2043-9     Citation Subset:  IM    
Affiliation:
Department of Orofacial Sciences, University of California at San Francisco, San Francisco, CA 94143-0422, U.S.A.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Neoplasm / metabolism*
Antigens, Surface / metabolism
Blotting, Western
Carcinoma, Squamous Cell / metabolism*,  pathology
Fluorescent Antibody Technique
Humans
Immunoenzyme Techniques
Integrins / metabolism*
Mouth Neoplasms / metabolism*,  pathology*
Neoplastic Stem Cells / metabolism*,  pathology
Proteoglycans / metabolism
Tumor Cells, Cultured
Wound Healing
Grant Support
ID/Acronym/Agency:
R01DE11930/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, Neoplasm; 0/Antigens, Surface; 0/Integrins; 0/Proteoglycans; 0/TRA-1-60 antigen, human; 0/integrin alphavbeta6

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heat-shock Protein 90 (Hsp90) as a Molecular Target for Therapy of Gastrointestinal Cancer.
Next Document:  Decreased levels of both stat1 and stat3 in T lymphocytes from mice bearing mammary tumors.